Form 4: Aspira Women's Health Interim CFO Acquires Stock Options

Interim CFO John Kallassy reports the acquisition of stock options in Aspira Women's Health Inc.

Summary

• John Kallassy, Interim CFO of Aspira Women's Health Inc., filed a Form 4 with the SEC.
• The filing reports a transaction that occurred on August 15, 2024.
• Kallassy acquired 25,000 stock options with an exercise price of $1.10.
• The options vest in six equal monthly installments starting on the grant date and expire on August 15, 2034.
• Following the transaction, Kallassy directly owns 25,000 derivative securities.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. The acquisition of stock options by an executive could be interpreted as a mildly positive signal, but it's a routine occurrence.

Positives

• The acquisition of stock options by the Interim CFO could be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The acquisition of stock options by the Interim CFO may have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Form 4, stock options, Aspira Women's Health, John Kallassy, Interim CFO, beneficial ownership, securities